Emerging treatments for lupus nephritis: health equity considerations in clinical research and coverage.

J Manag Care Spec Pharm

Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, La Jolla.

Published: October 2021

No funding was received for the writing of this commentary. The authors report no conflicts of interest.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390942PMC
http://dx.doi.org/10.18553/jmcp.2021.27.10.1500DOI Listing

Publication Analysis

Top Keywords

emerging treatments
4
treatments lupus
4
lupus nephritis
4
nephritis health
4
health equity
4
equity considerations
4
considerations clinical
4
clinical coverage
4
coverage funding
4
funding received
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!